두개내 동맥류 시장 규모, 점유율, 동향 분석 보고서 : 유형별, 최종 용도별, 지역별, 부문 예측(2025-2030년)

Intracranial Aneurysm Market Size, Share & Trends Analysis Report By Type, (Surgical Clipping, Endovascular Coiling, Flow Diverters), By End-use (Hospitals, Clinics), By Region, And Segment Forecasts, 2025 - 2030

US $ 5,950 ￦ 8,521,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 9,953,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 12,818,000

Printable PDF & Excel (Enterprise License)

PDF & Excel 보고서를 동일 기업(자회사 포함)의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.

한글목차

두개내 동맥류 시장 성장과 동향

Grand View Research, Inc.의 최신 보고서에 따르면 세계의 두개내 동맥류 시장 규모는 2030년에 27억 4,000만 달러에 달할 것으로 예측되며, 2025-2030년에 걸쳐 CAGR 9.9%를 나타낼 것으로 전망됩니다.

이 시장의 성장은 뇌졸중 증례 증가, 뇌혈관 장애를 앓는 사람들의 발생률 증가, 주요 기업에 의한 지속적인 제품 발매 등 다양한 요인에 기인하고 있습니다. 뇌졸중의 원인은 명확하게 밝혀지지 않았습니다. 그러나 노화, 뇌 외상, 유전성, 고혈압, 동맥 경화, 감염, 앉지 않은 라이프 스타일 등이 증상과 관련된 다양한 요인이 있습니다.

그 결과, 두개내 동맥류에 영향을 주는 인구 증가가 시장 확대에 기여하고 있습니다. 예를 들어, 2022년 6월, 인도 메드트로닉에서 뇌동맥류 혈관 내 치료를 위해 개발한 4세대 유량 디플렉터인 쉴드 기술이 적용된 파이프라인 밴티지(Pipeline Vantage)가 CE 마크를 획득했습니다. 표적 혈관의 최내층에서 세포의 발달을 촉진하는 골격을 개발하는 것으로, 의사가 뇌동맥류나 두개내 동맥류를 전달, 전개, 수복하는 것을 보다 쉽고 확실하게 합니다.

두개내 동맥류 시장 보고서 하이라이트

• 세계 시장에서는 혈관 내 치료기기와 전달시스템 모두에서 혁신이 진행되어 상당한 정도의 기술 혁신이 보였습니다.
• 혈관 내 코일링 부문이 2024년에 72.4%의 최대 매출 점유율로 시장을 견인했습니다.
• 플로우 다이버터 부문은 예측 기간 중 가장 빠른 CAGR 13.4%를 나타낼 것으로 전망됩니다.
• 병원 부문은 세계의 두개내 동맥류 시장을 독점해, 2024년에는 88.9%의 최대의 수익 점유율을 차지했습니다.
• 북미의 두개내 동맥류 시장은 확립된 의료 인프라의 존재, 고령자 증가, 고혈압과 뇌졸중의 높은 발생률에 의해 세계 시장을 독점해, 2024년에 27.6%의 최대의 수익 점유율을 차지했습니다.

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 세계의 두개내 동맥류 시장 변수, 동향, 범위

• 시장 계통의 전망
  • 모 시장 전망
  • 관련/보조시장 전망
• 시장 역학
  • 시장 성장 촉진요인 분석
  • 시장 성장 억제요인 분석
• 세계의 두개내 동맥류 시장 분석 툴
  • 산업 분석 - Porter's Five Forces 분석
  • PESTLE 분석

제4장 세계의 두개내 동맥류 시장 : 유형별 비즈니스 분석

• 유형 부문 대시보드
• 두개내 동맥류 시장 : 유형 변동 분석
• 세계의 두개내 동맥류 시장 규모와 동향 분석 - 유형별(2018-2030년)
• 수술용 클리핑
• 혈관 내 코일링

제5장 세계의 두개내 동맥류 시장 : 최종 용도별 비즈니스 분석

• 최종 용도 부문 대시보드
• 두개내 동맥류 시장 : 최종 용도 변동 분석
• 세계의 두개내 동맥류 시장 규모와 동향 분석 - 최종 용도별(2018-2030년)
• 병원
• 클리닉
• 기타

제6장 세계의 두개내 동맥류 시장 : 지역별, 추정 및 동향 분석

• 지역별 시장 대시보드
• 지역별 시장 점유율 분석(2024년, 2030년)
• 지역의 두개내 동맥류 시장 : 주요 포인트
• 북미
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 독일
  • 영국
  • 프랑스
  • 이탈리아
  • 스페인
  • 덴마크
  • 스웨덴
  • 노르웨이
• 아시아태평양
  • 일본
  • 중국
  • 인도
  • 호주
  • 태국
  • 한국
• 라틴아메리카
  • 브라질
  • 아르헨티나
• 중동 및 아프리카
  • 남아프리카
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 쿠웨이트

제7장 경쟁 구도

• 주요 시장 진출기업에 의한 최근의 동향과 영향 분석
• 기업/경쟁의 분류
• 공급업체 상황
  • 주요 기업 히트맵 분석(2024년)
• 기업 프로파일
  • Medtronic plc
  • Stryker Corporation
  • MicroPort Scientific Corporation
  • Johnson & Johnson Services, Inc.
  • MicroVention Inc.
  • B. Braun Melsungen AG
  • Integra LifeSciences
  • RAUMEDIC AG
  • Terumo Corporation
  • Delta Surgical

KTH

영문 목차

영문목차

Intracranial Aneurysm Market Growth & Trends:

The global intracranial aneurysm market size is anticipated to reach USD 2.74 billion in 2030 and is projected to grow at a CAGR of 9.9% from 2025 to 2030, according to a new report by Grand View Research, Inc. The growth of the market is attributed to various factors, such as increased cases of stroke, increasing incidence of people suffering from cerebrovascular disorders, and continuous product launches by key players. Furthermore, the market is growing rapidly in developing nations with expanding disposable income levels and improved access to healthcare. Currently, the cause of brain aneurysms is not clearly understood. However, there are various factors linked to this condition, including aging, brain trauma, hereditary, high blood pressure, atherosclerosis, infections, and a sedentary lifestyle. Notable symptoms encompass cranial nerve dysfunction, localized headaches, and double vision.

Consequently, the growing population of individuals afflicted with intracranial aneurysms is contributing to the market expansion. Businesses in this field are always looking for ways to make existing therapies safer and more effective while also introducing new technologies, which are anticipated to increase the demand for intracranial aneurysm products globally. For instance, in June 2022, Pipeline Vantage with Shield Technology, a fourth-generation flow deflector with a CE mark by India Medtronic, was developed for endovascular therapy for cerebral aneurysms. A newly developed flow deflector, Pipeline Vantage, features Shield technology and has enhanced features of the design for both the delivery system and the implant. By developing a scaffold that promotes the development of cells in the innermost layer of the target blood vessel, these qualities make it easier and more reliable for doctors to deliver, deploy, and repair brain aneurysms and intracranial aneurysms.

Intracranial Aneurysm Market Report Highlights:

• The global market has experienced a significant degree of innovation, with innovations in both endovascular devices and delivery systems.
• The endovascular coiling segment led the market with the largest revenue share of 72.4% in 2024. The endovascular coiling technique is a minimally invasive procedure that employs a catheter to identify and treat aneurysms in the brain.
• The flow diverters segment is expected to grow at the fastest CAGR of 13.4% over the forecast period. The continuous evolution of flow diverter technology boosts the market growth.
• The hospital segment dominated the global intracranial aneurysm market and accounted for the largest revenue share of 88.9% in 2024.
• North America intracranial aneurysm market dominated the global market and accounted for the largest revenue share of 27.6% in 2024 owing to the presence of well-established healthcare infrastructure, the rising geriatric population, and the high incidence of hypertension and stroke.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Type
  • 1.2.2. End Use
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased Database
  • 1.4.2. GVR's Internal Database
  • 1.4.3. Secondary Sources
  • 1.4.4. Primary Research
• 1.5. Information or Data Analysis
  • 1.5.1. Data Analysis Models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
• 1.8. List of Secondary Sources
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Type Outlook
  • 2.2.2. End Use Outlook
  • 2.2.3. Regional Outlook
• 2.3. Competitive Insights

Chapter 3. Global Intracranial Aneurysm Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Market Restraint Analysis
• 3.3. Global Intracranial Aneurysm Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
    • 3.3.1.1. Supplier Power
    • 3.3.1.2. Buyer Power
    • 3.3.1.3. Substitution Threat
    • 3.3.1.4. Threat of New Entrants
    • 3.3.1.5. Competitive Rivalry
  • 3.3.2. PESTLE Analysis
    • 3.3.2.1. Political Landscape
    • 3.3.2.2. Technological Landscape
    • 3.3.2.3. Economic Landscape

Chapter 4. Global Intracranial Aneurysm Market: Type Business Analysis

• 4.1. Type Segment Dashboard
• 4.2. Intracranial Aneurysm Market: Type Movement Analysis
• 4.3. Global Intracranial Aneurysm Market Size & Trend Analysis, By Type, 2018 to 2030 (USD Million)
• 4.4. Surgical Clipping
  • 4.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 4.5. Endovascular Coiling
  • 4.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 5. Global Intracranial Aneurysm Market: End Use Business Analysis

• 5.1. End Use Segment Dashboard
• 5.2. Intracranial Aneurysm Market: End Use Movement Analysis
• 5.3. Global Intracranial Aneurysm Market Size & Trend Analysis, By End Use, 2018 to 2030 (USD Million)
• 5.4. Hospitals
  • 5.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 5.5. Clinics
  • 5.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 5.6. Others
  • 5.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 6. Global Intracranial Aneurysm Market: Regional Estimates & Trend Analysis

• 6.1. Regional Market Dashboard
• 6.2. Regional Market Share Analysis, 2024 & 2030
• 6.3. Global Intracranial Aneurysm Market by Regional: Key Takeaways
• 6.4. North America
  • 6.4.1. U.S.
    • 6.4.1.1. Key Country Dynamics
    • 6.4.1.2. Regulatory Framework/ Reimbursement Structure
    • 6.4.1.3. Competitive Scenario
    • 6.4.1.4. U.S. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.4.2. Canada
    • 6.4.2.1. Key Country Dynamics
    • 6.4.2.2. Regulatory Framework/ Reimbursement Structure
    • 6.4.2.3. Competitive Scenario
    • 6.4.2.4. Canada Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.4.3. Mexico
    • 6.4.3.1. Key Country Dynamics
    • 6.4.3.2. Regulatory Framework/ Reimbursement Structure
    • 6.4.3.3. Competitive Scenario
    • 6.4.3.4. Mexico Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 6.5. Europe
  • 6.5.1. Germany
    • 6.5.1.1. Key Country Dynamics
    • 6.5.1.2. Regulatory Framework/ Reimbursement Structure
    • 6.5.1.3. Competitive Scenario
    • 6.5.1.4. Germany Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.5.2. UK
    • 6.5.2.1. Key Country Dynamics
    • 6.5.2.2. Regulatory Framework/ Reimbursement Structure
    • 6.5.2.3. Competitive Scenario
    • 6.5.2.4. UK Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.5.3. France
    • 6.5.3.1. Key Country Dynamics
    • 6.5.3.2. Regulatory Framework/ Reimbursement Structure
    • 6.5.3.3. Competitive Scenario
    • 6.5.3.4. France Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.5.4. Italy
    • 6.5.4.1. Key Country Dynamics
    • 6.5.4.2. Regulatory Framework/ Reimbursement Structure
    • 6.5.4.3. Competitive Scenario
    • 6.5.4.4. Italy Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.5.5. Spain
    • 6.5.5.1. Key Country Dynamics
    • 6.5.5.2. Regulatory Framework/ Reimbursement Structure
    • 6.5.5.3. Competitive Scenario
    • 6.5.5.4. Spain Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.5.6. Denmark
    • 6.5.6.1. Key Country Dynamics
    • 6.5.6.2. Regulatory Framework/ Reimbursement Structure
    • 6.5.6.3. Competitive Scenario
    • 6.5.6.4. Denmark Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.5.7. Sweden
    • 6.5.7.1. Key Country Dynamics
    • 6.5.7.2. Regulatory Framework/ Reimbursement Structure
    • 6.5.7.3. Competitive Scenario
    • 6.5.7.4. Sweden Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.5.8. Norway
    • 6.5.8.1. Key Country Dynamics
    • 6.5.8.2. Regulatory Framework/ Reimbursement Structure
    • 6.5.8.3. Competitive Scenario
    • 6.5.8.4. Norway Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 6.6. Asia Pacific
  • 6.6.1. Japan
    • 6.6.1.1. Key Country Dynamics
    • 6.6.1.2. Regulatory Framework/ Reimbursement Structure
    • 6.6.1.3. Competitive Scenario
    • 6.6.1.4. Japan Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.6.2. China
    • 6.6.2.1. Key Country Dynamics
    • 6.6.2.2. Regulatory Framework/ Reimbursement Structure
    • 6.6.2.3. Competitive Scenario
    • 6.6.2.4. China Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.6.3. India
    • 6.6.3.1. Key Country Dynamics
    • 6.6.3.2. Regulatory Framework/ Reimbursement Structure
    • 6.6.3.3. Competitive Scenario
    • 6.6.3.4. India Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.6.4. Australia
    • 6.6.4.1. Key Country Dynamics
    • 6.6.4.2. Regulatory Framework/ Reimbursement Structure
    • 6.6.4.3. Competitive Scenario
    • 6.6.4.4. Australia Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.6.5. Thailand
    • 6.6.5.1. Key Country Dynamics
    • 6.6.5.2. Regulatory Framework/ Reimbursement Structure
    • 6.6.5.3. Competitive Scenario
    • 6.6.5.4. Thailand Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.6.6. South Korea
    • 6.6.6.1. Key Country Dynamics
    • 6.6.6.2. Regulatory Framework/ Reimbursement Structure
    • 6.6.6.3. Competitive Scenario
    • 6.6.6.4. South Korea Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 6.7. Latin America
  • 6.7.1. Brazil
    • 6.7.1.1. Key Country Dynamics
    • 6.7.1.2. Regulatory Framework/ Reimbursement Structure
    • 6.7.1.3. Competitive Scenario
    • 6.7.1.4. Brazil Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.7.2. Argentina
    • 6.7.2.1. Key Country Dynamics
    • 6.7.2.2. Regulatory Framework/ Reimbursement Structure
    • 6.7.2.3. Competitive Scenario
    • 6.7.2.4. Argentina Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 6.8. Middle East & Africa
  • 6.8.1. South Africa
    • 6.8.1.1. Key Country Dynamics
    • 6.8.1.2. Regulatory Framework/ Reimbursement Structure
    • 6.8.1.3. Competitive Scenario
    • 6.8.1.4. South Africa Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.8.2. Saudi Arabia
    • 6.8.2.1. Key Country Dynamics
    • 6.8.2.2. Regulatory Framework/ Reimbursement Structure
    • 6.8.2.3. Competitive Scenario
    • 6.8.2.4. South Arabia Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.8.3. UAE
    • 6.8.3.1. Key Country Dynamics
    • 6.8.3.2. Regulatory Framework/ Reimbursement Structure
    • 6.8.3.3. Competitive Scenario
    • 6.8.3.4. UAE Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.8.4. Kuwait
    • 6.8.4.1. Key Country Dynamics
    • 6.8.4.2. Regulatory Framework/ Reimbursement Structure
    • 6.8.4.3. Competitive Scenario
    • 6.8.4.4. Kuwait Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Recent Developments & Impact Analysis, By Key Market Participants
• 7.2. Company/Competition Categorization
• 7.3. Vendor Landscape
  • 7.3.1. Key Company Heat Map Analysis, 2024
• 7.4. Company Profiles
  • 7.4.1. Medtronic plc
    • 7.4.1.1. Company Overview
    • 7.4.1.2. Financial Performance
    • 7.4.1.3. Product Benchmarking
    • 7.4.1.4. Strategic Initiatives
  • 7.4.2. Stryker Corporation
    • 7.4.2.1. Company Overview
    • 7.4.2.2. Financial Performance
    • 7.4.2.3. Product Benchmarking
    • 7.4.2.4. Strategic Initiatives
  • 7.4.3. MicroPort Scientific Corporation.
    • 7.4.3.1. Company Overview
    • 7.4.3.2. Financial Performance
    • 7.4.3.3. Product Benchmarking
    • 7.4.3.4. Strategic Initiatives
  • 7.4.4. Johnson & Johnson Services, Inc.
    • 7.4.4.1. Company Overview
    • 7.4.4.2. Financial Performance
    • 7.4.4.3. Product Benchmarking
    • 7.4.4.4. Strategic Initiatives
  • 7.4.5. MicroVention Inc.
    • 7.4.5.1. Company Overview
    • 7.4.5.2. Financial Performance
    • 7.4.5.3. Product Benchmarking
    • 7.4.5.4. Strategic Initiatives
  • 7.4.6. B. Braun Melsungen AG
    • 7.4.6.1. Company Overview
    • 7.4.6.2. Financial Performance
    • 7.4.6.3. Product Benchmarking
    • 7.4.6.4. Strategic Initiatives
  • 7.4.7. Integra LifeSciences
    • 7.4.7.1. Company Overview
    • 7.4.7.2. Financial Performance
    • 7.4.7.3. Product Benchmarking
    • 7.4.7.4. Strategic Initiatives
  • 7.4.8. RAUMEDIC AG
    • 7.4.8.1. Company Overview
    • 7.4.8.2. Financial Performance
    • 7.4.8.3. Product Benchmarking
    • 7.4.8.4. Strategic Initiative
  • 7.4.9. Terumo Corporation
    • 7.4.9.1. Company Overview
    • 7.4.9.2. Financial Performance
    • 7.4.9.3. Product Benchmarking
    • 7.4.9.4. Strategic Initiatives
  • 7.4.10. Delta Surgical
    • 7.4.10.1. Company Overview
    • 7.4.10.2. Financial Performance
    • 7.4.10.3. Product Benchmarking
    • 7.4.10.4. Strategic Initiatives

관련자료